分子心臓血管医学のためのゲノムベースのリソース:心臓血管遺伝子の要約に向けて
D M Hwang1, A A Dempsey, R X Wang
1Department of Laboratory Medicine, Centre for Cardiovascular Research, The Toronto Hospital, University of Toronto, Ontario, Canada.
Circulation
|January 7, 1998
まとめ
この研究では,発現配列タグ (EST) を使用して心臓血管遺伝子をカタログ化し,新しい遺伝子発現パターンと潜在的な疾患マーカーを明らかにしています. この研究は,分子心臓血管医学のための基礎的なリソースを提供します.
科学分野:
- ゲノミクスゲノミクスとは
- 分子生物学は分子生物学である.
- 心血管科学 心血管科学
背景:
- エクスプレスされた配列タグ (ESTs) は,新種の遺伝子発見と転写プロファイリングを容易にする.
- 心血管の遺伝子発現を特徴付けるために,ヒトの心臓のcDNAライブラリの大規模なシーケンシングが開始されました.
研究 の 目的:
- ヒトの心臓血管系内の遺伝子アイデンティティと発現レベルをカタログ化する.
- 分子循環器医学のための包括的なリソースを確立する.
主な方法:
- 人間の心臓のcDNAライブラリから43,285個の発現配列タグ (EST) を生成しました.
- 41,619の公共のESTを統合し,合計84,904のEST (2600万個以上の核酸) を獲得しました.
- 分類された既知の遺伝子は,機能によって一致し,シリコノース分析で行われました.
主要な成果:
- ESTの55%は既知の遺伝子と一致し,33%は他のESTと一致し,12%は新規 (CVbESTs) でした.
- 特定された組織および発達段階特有の遺伝子発現パターン.
- 心筋縮で過剰発現する可能性がある48の遺伝子が検出されました. これには,以前に知られていた10の異なる発現遺伝子が含まれています.
結論:
- これは,これまでで最も広範な心血管性遺伝子発現データを集めたものです.
- 心血管生物学におけるゲノム研究の可能性を強調する.
- 分子循環器医学のための第1世代のゲノムベースのリソースを確立する.
関連する概念動画
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...


